Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Werewolf Therapeutics (HOWL) Interest & Investment Income (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Interest & Investment Income for 5 consecutive years, with $697000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest & Investment Income fell 56.38% to $697000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $3.9 million, a 59.31% decrease, with the full-year FY2024 number at $6.7 million, down 10.02% from a year prior.
  • Interest & Investment Income was $697000.0 for Q3 2025 at Werewolf Therapeutics, down from $850000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $4.1 million in Q4 2023 to a low of -$34000.0 in Q4 2021.
  • A 5-year average of $1.1 million and a median of $997000.0 in 2025 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: surged 3794.87% in 2023, then crashed 68.1% in 2024.
  • Werewolf Therapeutics' Interest & Investment Income stood at -$34000.0 in 2021, then soared by 3567.65% to $1.2 million in 2022, then skyrocketed by 248.09% to $4.1 million in 2023, then plummeted by 68.1% to $1.3 million in 2024, then plummeted by 46.75% to $697000.0 in 2025.
  • Per Business Quant, the three most recent readings for HOWL's Interest & Investment Income are $697000.0 (Q3 2025), $850000.0 (Q2 2025), and $997000.0 (Q1 2025).